$CBDL CBD Life Sciences, Inc. (CBDL) Makes Progres
Post# of 1068
(Total Views: 453)
Posted On: 11/03/2021 9:10:48 AM
$CBDL CBD Life Sciences, Inc. (CBDL) Makes Progress to Triple Its Cartridge Production for Multinational Companies
https://www.accesswire.com/670871/cbd-life-sc...-companies
SCOTTSDALE, AZ / ACCESSWIRE / November 3, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly-owned subsidiary, LBC Bioscience Inc. announces that the company is making considerable progress to triple its cartridge production for multinational companies.
CBD Life Sciences Inc. is currently ramping up its production of cartridges due to such high demand from other companies. These multinational companies CBD Life Sciences is doing business with are in the pharmaceutical sector throughout the world. President & CEO Lisa Nelson states "With the addition of this new machine to make the cartridges, we can expect to make at least 1000 cartridges per day!" Lisa Nelson also states, "This will be a terrific way to increase revenue along with encountering huge growth opportunities as we continue to work with more and more companies who want our product on their shelves." What differentiates CBD Life Sciences Inc from the competition is all their Full Spectrum Cannabinoids contain over 7 (seven) cannabinoids offering all the benefits the industrial hemp plant has to offer. Due to using CO2 Extraction, you may find; CBD, CBDa, CBG, CBGa, CBN, CBC, & CBDV in all products as well as; Terpenoids, Aminos, Omegas, Saponins, and Flavonoids The company also decided to add six more strains to the list to provide even more of a choice for buyers.
Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the global cannabidiol market is anticipated to grow at a lucrative rate over the forecast period. Increasing awareness of cannabidiol's therapeutic benefits has influenced a buyer to buy cannabidiol products, regardless of their cost. As these have a greater profit margin, commercial retailers are now focusing on selling cannabis-based products. Numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance. In addition, CVS Health decides to offer CBD topicals all over its 800 stores and Walgreens Boots Alliance is selling CBD-containing topicals across 1500 of its stores in the U.S. Report from Fortune Business Insights said that the global cannabidiol (CBD) market size was USD 2,770.8 million in 2020. They also stated that the market is projected to grow from USD 3,675.1 million in 2021 to USD 55,791.3 million in 2028 at a CAGR of 47.49% between 2021 and 2028.
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
https://www.accesswire.com/670871/cbd-life-sc...-companies
SCOTTSDALE, AZ / ACCESSWIRE / November 3, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly-owned subsidiary, LBC Bioscience Inc. announces that the company is making considerable progress to triple its cartridge production for multinational companies.
CBD Life Sciences Inc. is currently ramping up its production of cartridges due to such high demand from other companies. These multinational companies CBD Life Sciences is doing business with are in the pharmaceutical sector throughout the world. President & CEO Lisa Nelson states "With the addition of this new machine to make the cartridges, we can expect to make at least 1000 cartridges per day!" Lisa Nelson also states, "This will be a terrific way to increase revenue along with encountering huge growth opportunities as we continue to work with more and more companies who want our product on their shelves." What differentiates CBD Life Sciences Inc from the competition is all their Full Spectrum Cannabinoids contain over 7 (seven) cannabinoids offering all the benefits the industrial hemp plant has to offer. Due to using CO2 Extraction, you may find; CBD, CBDa, CBG, CBGa, CBN, CBC, & CBDV in all products as well as; Terpenoids, Aminos, Omegas, Saponins, and Flavonoids The company also decided to add six more strains to the list to provide even more of a choice for buyers.
Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the global cannabidiol market is anticipated to grow at a lucrative rate over the forecast period. Increasing awareness of cannabidiol's therapeutic benefits has influenced a buyer to buy cannabidiol products, regardless of their cost. As these have a greater profit margin, commercial retailers are now focusing on selling cannabis-based products. Numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance. In addition, CVS Health decides to offer CBD topicals all over its 800 stores and Walgreens Boots Alliance is selling CBD-containing topicals across 1500 of its stores in the U.S. Report from Fortune Business Insights said that the global cannabidiol (CBD) market size was USD 2,770.8 million in 2020. They also stated that the market is projected to grow from USD 3,675.1 million in 2021 to USD 55,791.3 million in 2028 at a CAGR of 47.49% between 2021 and 2028.
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
(0)
(0)CBD Life Sciences Inc. (CBDL) Stock Research Links
Scroll down for more posts ▼